Steve Rosenman's  Instablog

Steve Rosenman
Send Message
Mr. Rosenman has nearly 15-years executive experience in the health and wellness sectors, including weight loss, cosmetics skincare and nutrition, both Rx and OTC. Expertise areas include strategic market and product planning and corporate development (evaluation, recommendation and execution of... More
  • New AMRN Developments 7 comments
    Jun 7, 2013 11:09 PM | about stocks: AMRN

    Few things:

    AF was right to mention the possibility of FDA panel prior to Anchor approval. It was new news released at Jeffreies conference. No risk really, as guidance panels first look at safety, then efficacy for the indication, AMRN has both. Hey, if the weight loss drugs can get approval on the panel, Anchor will be a fart in the wind.

    On to more interesting things from Jeffries..Company confirmed statin data on the way early summer; management confirmed they are in talks now to either be acquired or nail partnership with big pharma 2H2013 for Anchor. Company also sees FDA panel (if it happens) as positive event, and reminds of SPA and Reduce It substantially underway for it.

    I'd expect us to drift higher on this positive guidance. On good statin data, back to the teens we go. A panel vote could get us to interim new highs before we go higher on BD news or actual Anchor approval.

    A few people have emailed asking about FRX takeout rumors...yes, I have heard those rumors over the past 36 hours and a deal could make sense, but I'm not sure I buy it. FRX has more of a partner/license model. I still look to PFE, GSK and AZN to be best suited candidates, although people over there seem to be on substances not necessarily controlled by FDA with the OMTH move, so I'm going to discount them until they start doing some deals that make sense. Elan was offered substantially more $ today, but that deal is unlikely, not sure who is in control of that company now.

    Fun stuff ahead, place your bets... You know where I stand

    Stocks: AMRN
Back To Steve Rosenman's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (7)
Track new comments
  • moeschempf
    , contributor
    Comments (30) | Send Message
    Agree with PFE being the top candidate. I still think TEVA is in the game. MRK might step up to the plate. Sanofi could be the 100-1 dark horse that no one is looking at at this point.
    8 Jun 2013, 09:52 AM Reply Like
    , contributor
    Comments (116) | Send Message
    What did mgmt say in regards to the comment about acquired or partnership? I missed that. Was it in the Q and A? " management confirmed they are in talks now to either be acquired or nail partnership with big pharma 2H2013 for Anchor."
    8 Jun 2013, 01:15 PM Reply Like
  • Danburydude
    , contributor
    Comments (112) | Send Message
    About the two weight loss drugs, I am still floored either one got approved. I cannot imagine anyone who would want to put either of those two drugs into their body. You are correct that if those two got approved, ANCHOR should be a lead pipe cinch.
    But with all this funny stuff coming out about Washington right now, you have to wonder. You would like to believe the FDA is on the up and up, but anymore you really just don't know. Six months ago I would have called myself a whacked out conspiracy theorist for saying something like that. Nowadays...........?
    8 Jun 2013, 03:20 PM Reply Like
  • sts66
    , contributor
    Comments (3358) | Send Message
    "About the two weight loss drugs, I am still floored either one got approved."


    Q getting approved was definitely a shock, but not B - if you knew the background of both drugs you'd know why. What's even more shocking is that this week the FDA actually recommended easing the requirements on Avandia instead of totally banning it - that's a drug that has caused thousands upon thousands of heart attacks and actually killed people!


    Amarin owns an almost perfect CV drug, works on so many beneficial levels it's not funny, and ZERO side effects. Combine V with B and you've got a world beater!
    9 Jun 2013, 12:49 PM Reply Like
  • Steve Rosenman
    , contributor
    Comments (765) | Send Message
    Author’s reply » SPA is in writing, so Imnot worried.
    8 Jun 2013, 04:52 PM Reply Like
  • wayouy
    , contributor
    Comments (34) | Send Message
    Think about this, THIS IS WAR, what weapons do we have? DD and that’s after the fact. If good/bad news is coming out how do you know? The reason one buys stock is buy doing their DD that’s one of the steps in buying any stock in the first place right? Im convinced that proper charting also tells when and where events will take place. There are forces in the market place that even the MM cannot control, even though they try real hard and I add do their job very well.


    FWIW AF and company got Burned on AMRN RS, losing hundreds of thousands, thats why they are continually attacking the company. They will never recoup the loss. The problem they face is the time for manulipation grows short. They will push the buttons again and eventually get burned again. MM will not lose control for long.
    9 Jun 2013, 02:40 AM Reply Like
  • rydad21
    , contributor
    Comments (34) | Send Message
    BTW, Just a thank you for the heads up on ACLS.
    10 Jun 2013, 03:00 PM Reply Like
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.